Department of Finance and Economics, School of Internet Economics and Business, Fujian University of Technology, Fuzhou City, Fujian Province, China
Research Article
Which COVID-19 Vaccine is Efficiently Most Cost-Effective and Why?
Author(s): Rabnawaz Khan*
This study presents the dynamic boost of the COVID-19 vaccines. The intensive approach is indicating how the
effective COVID-19 vaccine promotes and distributes into various official channels. The Cost-Effectiveness Analysis
(CEA) approach is used with Quality-Adjusted Life Years (QALYs). The key findings are revealing the length of life
improves the quality of life of the middle family. The QALYs show that Utility Value (UV) by health and the value of
statistics in countries in the term of coexistent causation of vaccines. The Pfizer (BNT162b2) and Moderna (mRNA-
1273) have instantly created favourable and significant effects probably on many patients, comparatively SARSCoV-
2, AstraZeneca (AZD1222), Russia’s Sputnik (AstraZeneca), and Sinopharm Sinovac Biotech. The opportunity
cost provides a valuable benefit in the future. .. View more»